Análisis de supervivencia a corto y largo plazo del hepatocarcinoma tratado mediante resección o trasplante hepático

  1. MAGADÁN ÁLVAREZ, CRISTINA
Zuzendaria:
  1. Juan Carlos Rodríguez Sanjuán Zuzendaria

Defentsa unibertsitatea: Universidad de Cantabria

Fecha de defensa: 2023(e)ko apirila-(a)k 21

Epaimahaia:
  1. Luis Muñoz Bellvís Presidentea
  2. Fernando Luis Hernanz de la Fuente Idazkaria
  3. Andrés Valdivieso López Kidea

Mota: Tesia

Teseo: 801633 DIALNET lock_openTESEO editor

Laburpena

Hepatocellular carcinoma is the most common primary liver tumor. It is the third cause of death from neoplasia and the first in cirrhotic patients. In early stages, curative treatment is indicated, including surgery (liver resection or liver transplantation) or ablative techniques. Liver resection is the treatment of choice for tumor lesions in non-cirrhotic livers. In cirrhotic patients, liver transplantation is preferred due to its resolution of both tumor disease and the underlying disease. In the present study, mortality, recurrence, overall, specific and disease-free survival of patients with hepatocellular carcinoma treated by liver resection or liver transplantation are analyzed and compared along 10 years in a tertiary referral hospital.